• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过合成可能的连续肽段研究甲状腺过氧化物酶中的抗原决定簇。

Investigation of antigenic determinants in thyroid peroxidase by synthesis of possible sequential peptides.

作者信息

Hamada N, Okamoto Y, Yamakawa J, Ohno M, Noh J, Yano T, Shibata M, Ito K, Morii H

机构信息

Thyroid Study Unit, Sumire Hospital, Osaka Social Welfare Foundation, Japan.

出版信息

Osaka City Med J. 1993 Jun;39(1):57-66.

PMID:7694219
Abstract

One way to locate antigenic determinants in thyroid peroxidase (TPO) is to evaluate the binding of chemically synthesized peptides to autoantibodies. A major epitope of TPO involved in thyroid autoimmunity has been reported to be at residues 590 to 675. Therefore, we synthesized three peptides (P1, residues 603-610; P2, 615-630; and P3, 654-665) in the most antigenic part of this range, as judged by antigenicity analysis, and measured their antigenicity by enzyme-linked immunosorbent assay (ELISA). Amino groups protected with fluorenyl-methoxycarbonyl were used in the synthesis. Sera from 42 untreated patients with Hashimoto's disease and 30 untreated patients with Graves' disease were tested for binding with each peptide. In addition, 6 sera with antibodies against denatured and reduced microsomal antigen were tested. Sera obtained from 22 normal subjects were used as a control. Binding of sera from the patients with autoimmune thyroid disease to the synthetic peptides was weak, about 1% of binding to thyroid microsomes prepared from Graves' thyroid. However, the ELISA index of a mixture of P1, P2, and P3 was significantly higher in the patients with Hashimoto's disease than in the healthy subjects. For both P2 and P3, the ELISA index of the sera with antibodies against denatured and reduced TPO was higher than that of the sera from normal subjects. These results suggested 1) that the antigenic epitopes of TPO recognized by autoantibodies may be conformational and discontinuous, and 2) that antibodies against these linear portions of TPO may exist in patients with Hashimoto's disease.

摘要

确定甲状腺过氧化物酶(TPO)中抗原决定簇的一种方法是评估化学合成肽与自身抗体的结合情况。据报道,参与甲状腺自身免疫的TPO主要表位位于590至675位残基处。因此,根据抗原性分析,我们在该范围最具抗原性的部分合成了三种肽(P1,603 - 610位残基;P2,615 - 630位残基;P3,654 - 665位残基),并通过酶联免疫吸附测定(ELISA)测量它们的抗原性。合成过程中使用了用芴甲氧羰基保护的氨基。对42例未经治疗的桥本氏病患者和30例未经治疗的格雷夫斯病患者的血清进行了与每种肽结合情况的检测。此外,还检测了6份含有抗变性和还原微粒体抗原抗体的血清。将22名正常受试者的血清用作对照。自身免疫性甲状腺疾病患者的血清与合成肽的结合较弱,约为与从格雷夫斯病甲状腺制备的甲状腺微粒体结合的1%。然而,桥本氏病患者中P1、P2和P3混合物的ELISA指数显著高于健康受试者。对于P2和P3,含有抗变性和还原TPO抗体的血清的ELISA指数均高于正常受试者的血清。这些结果表明:1)自身抗体识别的TPO抗原表位可能是构象性和不连续的;2)桥本氏病患者体内可能存在针对TPO这些线性部分的抗体。

相似文献

1
Investigation of antigenic determinants in thyroid peroxidase by synthesis of possible sequential peptides.通过合成可能的连续肽段研究甲状腺过氧化物酶中的抗原决定簇。
Osaka City Med J. 1993 Jun;39(1):57-66.
2
Heterogeneity of autoantibodies against thyroid peroxidase in autoimmune thyroid disease: evidence against antibodies directly inhibiting peroxidase activity as regulatory factors in thyroid hormone metabolism.自身免疫性甲状腺疾病中抗甲状腺过氧化物酶自身抗体的异质性:反对抗体直接抑制过氧化物酶活性作为甲状腺激素代谢调节因子的证据。
J Clin Endocrinol Metab. 1991 Jan;72(1):188-95. doi: 10.1210/jcem-72-1-188.
3
Differential autoantibody responses to thyroid peroxidase in patients with Graves' disease and Hashimoto's thyroiditis.格雷夫斯病和桥本甲状腺炎患者对甲状腺过氧化物酶的自身抗体差异反应。
J Clin Endocrinol Metab. 1993 Oct;77(4):1098-101. doi: 10.1210/jcem.77.4.8408460.
4
Thyroid peroxidase activity-inhibiting immunoglobulins in patients with autoimmune thyroid disease.自身免疫性甲状腺疾病患者体内的甲状腺过氧化物酶活性抑制性免疫球蛋白
J Clin Endocrinol Metab. 1989 Apr;68(4):730-4. doi: 10.1210/jcem-68-4-730.
5
Evidence for the highly conformational nature of the epitope(s) on human thyroid peroxidase that are recognized by sera from patients with Hashimoto's thyroiditis.桥本甲状腺炎患者血清所识别的人甲状腺过氧化物酶上抗原决定簇高度构象性质的证据。
J Clin Endocrinol Metab. 1990 Jul;71(1):53-9. doi: 10.1210/jcem-71-1-53.
6
Application of mouse monoclonal antibodies for identification of antigen regions of human thyroid peroxidase in adolescents with Graves' disease and non-toxic multinodular goiter by flow cytometry.应用小鼠单克隆抗体通过流式细胞术鉴定Graves病和非毒性多结节性甲状腺肿青少年患者中人甲状腺过氧化物酶的抗原区域。
Autoimmunity. 2005 Dec;38(8):605-11. doi: 10.1080/08916930500315084.
7
The human anti-thyroid peroxidase autoantibody repertoire in Graves' and Hashimoto's autoimmune thyroid diseases.格雷夫斯病和桥本氏自身免疫性甲状腺疾病中的人类抗甲状腺过氧化物酶自身抗体库。
Immunogenetics. 2002 Jun;54(3):141-57. doi: 10.1007/s00251-002-0453-9. Epub 2002 May 3.
8
The quantitative measurement of autoantibodies to thyroglobulin and thyroid peroxidase by automated microparticle based immunoassays in Hashimoto's disease, Graves' disease and a follow-up study on postpartum thyroid disease.通过基于自动化微粒的免疫测定法对桥本氏病、格雷夫斯病患者甲状腺球蛋白和甲状腺过氧化物酶自身抗体进行定量测定以及产后甲状腺疾病的随访研究。
Clin Lab. 2000;46(1-2):57-61.
9
[Diagnostic value of autoantibodies against microsomal thyroid peroxidase (anti-TPO)].抗微粒体甲状腺过氧化物酶自身抗体(抗-TPO)的诊断价值
Schweiz Med Wochenschr. 1992 Dec 26;122(51-52):1976-80.
10
An analysis of the structure and antigenicity of different forms of human thyroid peroxidase.不同形式的人甲状腺过氧化物酶的结构与抗原性分析。
Thyroid. 1994 Summer;4(2):173-8. doi: 10.1089/thy.1994.4.173.